PRUNE2
PRUNE2 (prune homolog 2 with BCH domain, also known as BMCC1, BNIPXL and KIAA0367) is a cytoplasmic member of the PRUNE family. It is linked to the differentiation, survival and aggressiveness of tumour cells, and acts as a tumour suppressor in prostate cancer cells. Browse Assay Genie's current range of PRUNE2 research reagents below, or read on for the biology behind the target.
PRUNE2 may play an important role in regulating the differentiation, survival and aggressiveness of tumour cells. Several functions have been demonstrated for the protein. These include suppression of Ras homolog family member A (RhoA) activity, which reduces stress fibre formation and suppresses oncogenic cellular transformation. A high molecular weight isoform has been shown to colocalise with adaptor protein complex 2, beta-adaptin and endodermal markers. This suggests a role in post-endocytic trafficking.
The protein encoded by the PRUNE2 gene belongs to the BCH domain family, named for B-cell CLL/lymphoma 2 and adenovirus E1B 19 kDa interacting proteins. Members of this family act in many cellular processes, including apoptosis, cell transformation and synaptic function. UniProt places PRUNE2 in the PPase class C family, Prune subfamily, and records it in the cytoplasm. HGNC classifies it within the BCH domain containing, CRAL-TRIO lipid binding domain containing and PRUNE family groups. Alternative splicing produces multiple transcript variants. Mouse and rat each have a Prune2 ortholog.
In prostate cancer cells, PRUNE2 acts as a tumour suppressor. Its expression is regulated by prostate cancer antigen 3 (PCA3), a non-protein-coding gene on the opposite DNA strand, within an intron of the PRUNE2 gene. PCA3 controls PRUNE2 levels by forming a double-stranded RNA with it. This RNA undergoes ADAR-dependent adenosine-to-inosine editing. The gene has also been called chromosome 9 open reading frame 65 (C9orf65) and prune homolog 2 (Drosophila).
PRUNE2 acts as a tumour suppressor in prostate cancer cells, and its expression is regulated by the antisense non-coding gene PCA3.
PRUNE2 may help regulate the differentiation, survival and aggressiveness of tumour cells, making it a subject of cancer biology studies.
PRUNE2 suppresses RhoA activity, reducing stress fibre formation and oncogenic cellular transformation.
A high molecular weight isoform colocalises with adaptor protein complex 2 and beta-adaptin, suggesting a role in post-endocytic trafficking.
PRUNE2 may play an important role in regulating differentiation, survival and aggressiveness of tumour cells. It suppresses RhoA activity, which reduces stress fibre formation and oncogenic transformation, and it acts as a tumour suppressor in prostate cancer cells. A high molecular weight isoform may be involved in post-endocytic trafficking.
PRUNE2 is also known as BMCC1, BNIPXL, C9orf65 and KIAA0367, and was formerly called prune homolog 2 (Drosophila). Alternative splicing gives multiple transcript variants, including a high molecular weight isoform that colocalises with adaptor protein complex 2 and beta-adaptin.
PCA3 is a non-protein-coding gene on the opposite strand, within an intron of the PRUNE2 gene. It regulates PRUNE2 levels by forming a double-stranded RNA that undergoes ADAR-dependent adenosine-to-inosine editing. In prostate cancer cells PRUNE2 acts as a tumour suppressor. Mouse and rat both have a Prune2 ortholog.
Pathway partners, PRUNE family members and RNA-editing factors linked to PRUNE2 biology.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q8WUY3; product specifications from Assay Genie datasheets.